Are small biotechs in trouble?
World of DTC Marketing
MARCH 14, 2022
It’s not only getting harder for small biotechs to find funding; too many have scaled up operations by adding employees too quickly, forcing them to lay off people as the path to new drug approvals gets more complicated. With two of its prized gene therapies on clinical hold, Bluebird, a small biotech company in Cambridge, is going through some hard times.
Let's personalize your content